Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life
Conditions: Glioma; Glioma, Malignant Interventions: Diagnostic Test: Resting State Functional Magnetic Resonance Imaging (rs-fMRI); Behavioral: Up-front Motor Rehabilitation; Drug: Up-front Chemotherapy Sponsors: University of Milan; University of Turin, Italy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials

Tracing Brain Tumors Through Deep Time
Conditions: Brain Tumor; Oncology Interventions: Diagnostic Test: Imaging with CT and MRI Sponsors: Tata Memorial Centre; Indian Statistical Institute, Kolkata Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials

Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas
Conditions: Low-grade Glioma Interventions: Drug: Tovorafenib Sponsors: Daniel Morgenstern; The Hospital for Sick Children Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials

FIH Clinical Investigation of Graphene Electrodes for Brain Mapping
Conditions: Brain Tumor; Glioma Interventions: Device: INBRAIN Graphene Cortical Interface Sponsors: University of Manchester; Northern Care Alliance NHS Foundation Trust; European Commission; Inbrain Neuroelectronics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials

Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
Conditions: Glioma; Glioblastoma Interventions: Procedure: sub-lobectomy; Procedure: imaging total resection Sponsors: Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials

TLX101-CDx (Pixclara) Granted FDA Fast Track Designation
Melbourne (Australia) | 16 April 2024 -- Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track designation1 for the Company’s investigational glioma imaging product, TLX101-CDx... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 16, 2024 Category: Pharmaceuticals Source Type: clinical trials

Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery
Conditions: Glioma Interventions: Diagnostic Test: Immunohistochemistry or genetic test Sponsors: Beijing Tiantan Hospital; West China Hospital; The First Affiliated Hospital of Zhengzhou University; Capital Medical University; Jiangsu Raman Medical Equipment Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials

99mTc-CNDG SPECT/CT in Brain Tumors
Conditions: Intracranial Tumor Interventions: Diagnostic Test: 99mTc-CNDG SPECT/CT Sponsors: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials

Visual Telerehabilitation in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour
Conditions: Hemianopsia Interventions: Device: Audiovisual stimulation Sponsors: University Health Network, Toronto; Alberta Children ' s Hospital; St. Justine ' s Hospital; The Hospital for Sick Children; British Columbia Children ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials

IL13R α2 CAR-T for Patients With r/r Glioma
Conditions: Glioma Interventions: Biological: IL13R α2 CAR-T Sponsors: Yang Zhang; TCRCure Biopharma Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Conditions: Pediatric Tumor of CNS; Pediatric Tumor of Brain; Diffuse Midline Glioma, H3 K27M-Mutant; Pediatric Tumor of Brain Stem; Pineocytoma; Choroid Plexus Carcinoma, Childhood; Spinal Cord Tumor; High Grade Glioma Interventions: Drug: NEO100 Sponsors: Neonc Technologies, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment - a Collaborative Observational Research Project
Conditions: Disc Disease; Instabilities Lumbar; Brain Tumor; Aneurysm Interventions: Other: OP-Tracker App Sponsors: Cantonal Hospital of St. Gallen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials

Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness
Conditions: Glioblastoma; Glioma; Glioma Glioblastoma Multiforme Interventions: Other: cell isolation from tumor biopsies and biomarker investigation Sponsors: Fondazione IRCCS Ca ' Granda, Ospedale Maggiore Policlinico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
Conditions: Astrocytoma; Glioma; Recurrent Glioblastoma Interventions: Radiation: Radiation Therapy Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials

A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma
Conditions: Diffuse Hemispheric Glioma, H3 G34-Mutant Interventions: Procedure: Biospecimen Collection; Biological: Dendritic Cell Therapy; Procedure: Leukapheresis; Procedure: Magnetic Resonance Imaging; Drug: Poly ICLC Sponsors: Jonsson Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials